相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Extracellular purines, purinergic receptors and tumor growth
F. Di Virgilio et al.
ONCOGENE (2017)
ERBB4 is over-expressed in human colon cancer and enhances cellular transformation
Christopher S. Williams et al.
CARCINOGENESIS (2015)
A Novel Cell-Permeable, Selective, and Noncompetitive Inhibitor of KAT3 Histone Acetyltransferases from a Combined Molecular Pruning/Classical Isosterism Approach
Ciro Milite et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
HSP105 Recruits Protein Phosphatase 2A To Dephosphorylate β-Catenin
Nancy Yu et al.
MOLECULAR AND CELLULAR BIOLOGY (2015)
Altering cancer transcriptomes using epigenomic inhibitors
Malaina Gaddis et al.
EPIGENETICS & CHROMATIN (2015)
The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets
Enzo Medico et al.
NATURE COMMUNICATIONS (2015)
Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cells
Elena Ciaglia et al.
ONCOTARGET (2015)
A2aR antagonists: Next generation checkpoint blockade for cancer immunotherapy
Robert D. Leone et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2015)
Identification of Structural Features of 2-Alkylidene-1,3-Dicarbonyl Derivatives that Induce Inhibition and/or Activation of Histone Acetyltransferases KAT3B/p300 and KAT2B/PCAF
Sabrina Castellano et al.
CHEMMEDCHEM (2015)
Localization of phosphorylated ErbB1-4 and heregulin in colorectal cancer
Keigo Mitsui et al.
BMC CANCER (2014)
Comprehensive analysis of β-catenin target genes in colorectal carcinoma cell lines with deregulated Wnt/β-catenin signaling
Andreas Herbst et al.
BMC GENOMICS (2014)
An Unconventional KITENIN/ErbB4-Mediated Downstream Signal of EGF Upregulates c-Jun and the Invasiveness of Colorectal Cancer Cells
Jeong A. Bae et al.
CLINICAL CANCER RESEARCH (2014)
Structural Evidence of N6-Isopentenyladenosine As a New Ligand of Farnesyl Pyrophosphate Synthase
Mario Scrima et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Neuroprotective Potential of Adenosine A2A and Cannabinoid CB1 Receptor Antagonists in an Animal Model of Parkinson Disease
Silvia Cerri et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2014)
New Steroids with a Rearranged Skeleton as (h)P300 Inhibitors from the Sponge Theonella swinhoei
Jun Gong et al.
ORGANIC LETTERS (2014)
Co-Expression of HER Family Members in Patients with Dukes' C and D Colon Cancer and Their Impacts on Patient Prognosis and Survival
Said Abdullah Khelwatty et al.
PLOS ONE (2014)
Frizzled homolog proteins, microRNAs and Wnt signaling in cancer
Koji Ueno et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974
Jun Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The beta-Catenin Destruction Complex
Jennifer L. Stamos et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Selective Small Molecule Targeting β-Catenin Function Discovered by In Vivo Chemical Genetic Screen
Jijun Hao et al.
CELL REPORTS (2013)
WNT signalling pathways as therapeutic targets in cancer
Jamie N. Anastas et al.
NATURE REVIEWS CANCER (2013)
The inverse agonist effect of rimonabant on G protein activation is not mediated by the cannabinoid CB1 receptor: Evidence from postmortem human brain
A. M. Erdozain et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Inverse Virtual Screening allows the discovery of the biological activity of natural compounds
Gianluigi Lauro et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells
Chiara Laezza et al.
EUROPEAN JOURNAL OF CANCER (2012)
Interaction of Endocannabinoid System and Steroid Hormones in the Control of Colon Cancer Cell Growth
Maria C. Proto et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
CB1-independent mechanisms of Δ9-THCV, AM251 and SR141716 (rimonabant)
R. B. Raffa et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2012)
Discovery and Synthesis of Namalide Reveals a New Anabaenopeptin Scaffold and Peptidase inhibitor
Pradeep Cheruku et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Genetic and pharmacologic inactivation of cannabinoid CB1 receptor inhibits angiogenesis
Simona Pisanti et al.
BLOOD (2011)
Inverse Virtual Screening of Antitumor Targets: Pilot Study on a Small Database of Natural Bioactive Compounds
Gianluigi Lauro et al.
JOURNAL OF NATURAL PRODUCTS (2011)
Wnt/β-Catenin Signaling Enhances Cyclooxygenase-2 (COX2) Transcriptional Activity in Gastric Cancer Cells
Felipe Nunez et al.
PLOS ONE (2011)
Receptors and Channels Targeted by Synthetic Cannabinoid Receptor Agonists and Antagonists
R. G. Pertwee
CURRENT MEDICINAL CHEMISTRY (2010)
Hypoxia-inducible adenosine A2B receptor modulates proliferation of colon carcinoma cells
De-Fu Ma et al.
HUMAN PATHOLOGY (2010)
Genome-wide assessment of differential roles for p300 and CBP in transcription regulation
Yolande F. M. Ramos et al.
NUCLEIC ACIDS RESEARCH (2010)
The opposing roles of Wnt-5a in cancer
S. L. McDonald et al.
BRITISH JOURNAL OF CANCER (2009)
Cannabinoid receptor-independent cytotoxic effects of cannabinoids in human colorectal carcinoma cells: synergism with 5-fluorouracil
Sofia B. Gustafsson et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
The COX-2/PGE(2) pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment
Alexander Greenhough et al.
CARCINOGENESIS (2009)
Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon
Antonietta Santoro et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Selective inhibition of proliferation in colorectal carcinoma cell lines expressing mutant APC or activated B-Raf
Hui-Hua Zhang et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
The endocannabinoid anandamide inhibits cholangiocarcinoma growth via activation of the noncanonical Wnt signaling pathway
Sharon DeMorrow et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
Loss of cannabinoid receptor 1 accelerates intestinal tumor growth
Dingzhi Wang et al.
CANCER RESEARCH (2008)
PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab
Minaxi Jhawer et al.
CANCER RESEARCH (2008)
The first five years of the Wnt targetome
Annica Vlad et al.
CELLULAR SIGNALLING (2008)
WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/beta-catenin signaling, and is frequently methylated in colorectal cancer
Jianming Ying et al.
CLINICAL CANCER RESEARCH (2008)
Cannabinoid Receptor Activation Induces Apoptosis through Tumor Necrosis Factor α - Mediated Ceramide De novo Synthesis in Colon Cancer Cells
Fabio Cianchi et al.
CLINICAL CANCER RESEARCH (2008)
Receptor tyrosine kinase Ror2 mediates Wnt5a-induced polarized cell migration by activating c-Jun N-terminal kinase via actin-binding protein filamin A
Akira Nomachi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The structural basis of protein acetylation by the p300/CBP transcriptional coactivator
Xin Liu et al.
NATURE (2008)
Increased endocannabinoid levels reduce the development of precancerous lesions in the mouse colon
Angelo A. Izzo et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2008)
The cannabinoid Δ9-tetrahydrocannabinol inhibits RAS-MAPK and PI3K-AKT survival signalling and induces BAD-mediated apoptosis in colorectal cancer cells
Alexander Greenhough et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Striatal adenosine A2A and Cannabinoid CB1 receptors form functional heteromeric complexes that mediate the motor effects of Cannabinoids
Paulina Carriba et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines:: Focus on the A3 adenosine subtype
Stefania Gessi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition
Elizabeth Buck et al.
MOLECULAR CANCER THERAPEUTICS (2007)
β-Catenin destruction complex:: insights and questions from a structural perspective
D. Kimelman et al.
ONCOGENE (2006)
The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid raft-mediated mechanism
Daniela Sarnataro et al.
MOLECULAR PHARMACOLOGY (2006)
Adenomatous polyposis coli (APC) differentially regulates β-catenin phosphorylation and ubiquitination in colon cancer cells
Jun Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Purified Wnt5a protein activates or inhibits β-catenin-TCF signaling depending on receptor context
AJ Mikels et al.
PLOS BIOLOGY (2006)
Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-β-catenin signaling axis
MD Castellone et al.
SCIENCE (2005)
Wnt and calcium signaling:: β-Catenin-independent pathways
AD Kohn et al.
CELL CALCIUM (2005)
Inhibition of primary colon carcinoma growth and liver metastasis by the A3 adenosine receptor agonist CF101
G Ohana et al.
BRITISH JOURNAL OF CANCER (2003)
The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK signalling pathway
I Oishi et al.
GENES TO CELLS (2003)
The TAK1-NLK mitogen-activated protein kinase cascade functions in the Wnt-5a/Ca2+ pathway to antagonize Wnt/beta-catenin signaling
T Ishitani et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
分享论文
